Literature DB >> 15908329

Effects of Salvia miltiorrhiza on intestinal microflora in rats with ischemia/reperfusion liver injury.

Hui-Chun Xing1, Lan-Juan Li, Kai-Jin Xu, Tian Shen, Yun-Bo Chen, Yu Chen, Su-Zhen Fu, Ji-Fang Sheng, Chun-Lei Chen, Jian-Guo Wang, Dong Yan, Fang-Wei Dai, Xiao-Ying Sha.   

Abstract

BACKGROUND: Hepatic ischemia/reperfusion injury may induce intestinal microflora imbalance. Salvia miltiorrhiza is effective in promoting blood circulation and counteracting peroxidation in tissues. The aim of the present study was to determine the effects of Salvia miltiorrhiza on intestinal microflora, endotoxemia, and bacterial translocation in rats with hepatic I/R injury.
METHODS: Sprague-Dawley rats in specific pathogen free grade were divided into 3 groups: group I(n=6) for sham operation; groups II(n=10) and III(n=7) for liver ischemia for 20 minutes and reperfusion for 22 hours. Group III was also pretreated with 4 ml/day of Salvia miltiorrhiza solution (250 mg/kg) by daily gavage for 7 days. The levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), malondialdehyde (MDA) and superoxide dismutase(SOD) in liver tissues, serum endotoxin, intestinal bacterial counts, intestinal mucosal histology and bacterial translocation were studied.
RESULTS: The levels of ALT, AST, plasma endotoxin and MDA in liver tissues were decreased more markedly in group III (57.57+/-18.08 U/L, 147.57+/-40.84 U/L, 0.42+/-0.144 EU/ml and 0.52+/-0.19 nmol/mg-prot respectively) in group II(122.8+/-80.12 U/L, 295.9+/-216.92 U/L, 0.80+/-0.262 EU/ml and 0.72+/-0.12 nmol/mg-prot; P<0.05-0.01 respectively). Liver SOD activity was increased more significantly in group III (318.47+/-64.62 U/mg-prot) than in group II(240.76+/-63.67 U/mg-prot, P<0.05). The counts of Bifidobacteria and Bacteroides increased more significantly in group III than in group II, but were similar to those in group I. Bacterial translocation to the kidney in group II was 50%(5/10), whereas no bacterial translocation to the kidney occurred in the other two groups (P<0.01). Ileal mucosal structure was markedly ameliorated in group III as compared with group II.
CONCLUSIONS: Salviae miltiorrhiza could partially restore intestinal microflora balance, improve intestinal mucosal integrity, and reduce bacterial translocation and plasma endotoxin in rats with hepatic ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15908329

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  6 in total

1.  Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy.

Authors:  Jing Zhao; Qing-Li Zhang; Jian-Hua Shen; Kai Wang; Jia Liu
Journal:  Acta Pharmacol Sin       Date:  2018-06-25       Impact factor: 6.150

2.  Matrine attenuates endotoxin-induced acute liver injury after hepatic ischemia/reperfusion in rats.

Authors:  Feng Zhang; Xun Wang; Liquan Tong; Haiquan Qiao; Xinlei Li; Liguang You; Hongchi Jiang; Xueying Sun
Journal:  Surg Today       Date:  2011-07-20       Impact factor: 2.549

3.  Salvianolic acid B promotes bone formation by increasing activity of alkaline phosphatase in a rat tibia fracture model: a pilot study.

Authors:  Xufeng He; Qiang Shen
Journal:  BMC Complement Altern Med       Date:  2014-12-15       Impact factor: 3.659

4.  Tanshinone IIA May Inhibit Gastric Cancer via Affecting the Intestinal Microbiome.

Authors:  Fenggang Lu; Yi Zhang; Pinghui Song; Yu Xu; Zhongkun Wu; Qinyu Wang; Naiying Shen
Journal:  Comput Math Methods Med       Date:  2022-09-26       Impact factor: 2.809

5.  Cardiovascular effects of salvianolic Acid B.

Authors:  Jie Wang; Xingjiang Xiong; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-10       Impact factor: 2.629

6.  Butyrate protects rat liver against total hepatic ischemia reperfusion injury with bowel congestion.

Authors:  Bin Liu; Jianmin Qian; Qingbao Wang; Fangrui Wang; Zhenyu Ma; Yingli Qiao
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.